Clinical Trials Browser

Phase EARLY_PHASE1 × Unknown × Other hematologic neoplasm × Clear all

NCT06277011 2024-02-26

Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10-19) in the Treatment of Relapsed and/or Refractory CD19-positive B Cell Hematological Malignancies Clinical Research

Phase EARLY_PHASE1 Unknown

LymphoidOther hematologic neoplasm

Lymphoma, Non-Hodgkin, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04504526 2023-09-15

Value of Chemokine Receptor CXCR4 Imaging for Diagnosis and Prognostic Evaluation in Lymphoproliferative Diseases

Phase EARLY_PHASE1 Unknown

LymphoidOther hematologic neoplasmPlasma cell

Leukemia, Lymphoma, Multiple Myeloma

NCT04923919 2023-07-13

Clinical Study of Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of Myeloid Leukemia

Phase EARLY_PHASE1 Unknown

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT05744440 2023-02-27

Safety and Efficacy of Allogenic NK Cells in Combination With Chemotherapy in the Treatment of r/r AML After Allo-HSCT

Phase EARLY_PHASE1 Unknown

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT05739227 2023-02-22

Safety and Efficacy of Allogenic CD19-CAR-NK Cells in Treatmenting r/r B-cell Hematologic Malignancies

Phase EARLY_PHASE1 Unknown

LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05722171 2023-02-10

Clinical Study of UTAA06 Injection in the Treatment of Relapsed/Refractory Acute Myeloid Leukemia

Phase EARLY_PHASE1 Unknown

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT05519384 2022-11-28

Safety and Preliminary Efficacy of JK500 Cell Injection in Relapsed/Refractory Pediatric Acute Myeloid Leukemia

Phase EARLY_PHASE1 Unknown

Other hematologic neoplasm

Leukemia, Leukemia, Myeloid, Acute

NCT05480501 2022-07-29

Clinical Trial to Evaluate the Safety and Efficacy of IM19 CAR-T Cells in Patients With Relapsed and Refractory (R/R) B-cell Acute Lymphoblastic Leukemia

Phase EARLY_PHASE1 Unknown

LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Leukemia

NCT05432401 2022-06-27

TAA05 Injection in the Treatment of Adult Patients With FLT3-positive Relapsed/Refractory Acute Myeloid Leukemia

Phase EARLY_PHASE1 Unknown

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT05215015 2022-01-31

Study of Anti-CD33/CLL1 CAR-NK in Acute Myeloid Leukemia

Phase EARLY_PHASE1 Unknown

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT05016063 2021-08-23

Dual CD33-CLL1-CAR-T Cells in the Treatment of Relapsed/Refractory Acute Myeloid Leukemia

Phase EARLY_PHASE1 Unknown

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT04264078 2021-06-28

Anti-CD7 U-CAR-T Cell Therapy for T/NK Cell Hematologic Malignancies

Phase EARLY_PHASE1 Unknown

LymphoidOther hematologic neoplasm

Leukemia, T-Cell, Lymphoma, T-Cell

NCT04700319 2021-03-08

CAR-T CD19/CD20 for Patients With Advanced CD19/CD20+ B Cell Line Recurrent or Refractory Hematological Malignancies

Phase EARLY_PHASE1 Unknown

Other hematologic neoplasm

Hematologic Neoplasms

NCT04767308 2021-02-23

Safety and Efficacy of CT125A Cells for Treatment of Relapsed/Refractory CD5+ Hematopoietic Malignancies

Phase EARLY_PHASE1 Unknown

LymphoidOther hematologic neoplasm

Lymphoma, Follicular, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Peripheral, Hematologic Neoplasms, Lymphoma, Mantle-Cell

NCT04439721 2021-01-06

γδT

Phase EARLY_PHASE1 Unknown

LymphoidOther hematologic neoplasm

Leukemia, Leukemia, B-Cell

NCT04626765 2020-11-13

CAR-T for Children With Relapsed and Refractory Acute Lymphoblastic Leukemia

Phase EARLY_PHASE1 Unknown

LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04209712 2020-07-29

Natural Killer Cells Infusion for Treating Acute Myeloid Leukemia Patients With Minimal Residual Disease

Phase EARLY_PHASE1 Unknown

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT04226989 2020-02-21

A Study of CT-RD06 Cell Injection in Patients With Relapsed or Refractory CD19+ B-cell Hematological Malignancy

Phase EARLY_PHASE1 Unknown

LymphoidOther hematologic neoplasm

Lymphoma, Non-Hodgkin, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04156243 2019-11-12

CD19 CARvac T Cells for Patients With Relapsed / Refractory B Cell Malignancies

Phase EARLY_PHASE1 Unknown

LymphoidOther hematologic neoplasm

Leukemia, B-Cell, Lymphoma, B-Cell

NCT04028440 2019-09-26

γδT Cells Immunotherapy in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma (NHL)

Phase EARLY_PHASE1 Unknown

LymphoidOther hematologic neoplasm

Lymphoma, Non-Hodgkin, Recurrence, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Lymphoma, T-Cell, Peripheral

NCT03910842 2019-09-06

Treatment of Children CD19+ Leukemia and Non-Hodgkin Lymphoma With CD19-TriCAR-T/SILK Cell Therapy

Phase EARLY_PHASE1 Unknown

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Non-Hodgkin

NCT04011293 2019-07-08

A Clinical Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Injection (CNCT19) in the Treatment of Cluster of Differentiation 19 (CD19) Positive Relapsed or Refractory B Cell Malignancies

Phase EARLY_PHASE1 Unknown

Other hematologic neoplasm

Neoplasms, Recurrence, Hematologic Neoplasms

NCT03228303 2017-10-10

Nilotinib Versus Imatinib in Treatment of Patients With Newly Diagnosed Chronic Myeloid Leukemia

Phase EARLY_PHASE1 Unknown

MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive